Latest Restructuring News

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

FirstWave Cloud Technology reports a significant reduction in losses for FY25, driven by operational restructuring and new AI initiatives, while setting sights on Latin American expansion.

RLF AgTech Ltd has reported a remarkable financial turnaround in FY25, with revenues more than doubling and losses narrowing significantly, setting the stage for expansion in FY26.

Clime Investment Management Limited has reported a significant turnaround in FY25, returning to profitability with a 13% revenue increase and proposing a fully franked final dividend. The company expanded its business lines and strengthened its leadership team, setting a positive outlook for FY26.

FBR Ltd reported a 57% revenue increase driven by property sales but posted a $29 million loss as it advances commercialization of its Hadrian X® robotic bricklayer and secures significant new funding.

Delorean Corporation reported a strategic shift in FY25, transitioning from third-party bioenergy construction to owning and operating renewable gas infrastructure, resulting in a $4.1 million loss but positioning the company for future multi-revenue growth.

AdNeo Limited reported a 14% rise in FY25 revenue driven by acquisitions, yet posted a $5.25 million net loss impacted by non-recurring items. Post-year-end capital raising and cost cuts position the company for growth.

Synertec Corporation reported an 8% revenue decline in FY25 but achieved a 15% improvement in normalised EBITDA, driven by a strong second-half rebound in Engineering and a 90% surge in Powerhouse revenue.

Yojee Limited reported a 34% revenue decline to $675k and a 29% reduction in net loss to $6.02 million for FY2025, reflecting a strategic pivot and accelerated development of its MOSAIC freight forwarding platform. The company raised $8.9 million to fund growth and platform commercialization.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.

Zicom Group Limited reported a 17% rise in net profit and a significant reduction in debt for FY2025, while adopting a cautious stance on dividends amid ongoing global economic uncertainties.

Synertec Corporation Limited reported an 8% revenue decline to $18.2 million in FY2025 alongside a $7.64 million net loss, yet its Engineering segment showed a strong EBITDA rebound and its Powerhouse renewable technology revenue nearly doubled.